Sarcoma Alliance For Research Through Collaboration

This study tests a new drug combination (bezuclastinib plus sunitinib) in 40 adults with advanced gastrointestinal stromal tumors (GIST) that worsened despite sunitinib treatment. The goal is to see if the combination can delay cancer growth. Participants take both drugs by mouth…

This study tests a combination of two drugs, regorafenib and nivolumab, in people with osteosarcoma (a type of bone cancer) that has come back or not responded to treatment. The goal is to see if this combination can stop the cancer from growing longer than regorafenib alone. Abo…